STOCK TITAN

Millennium group (SPR B) joint Schedule 13G shows ~103K shares (~9.6%)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Spruce Biosciences, Inc. reported a joint Schedule 13G showing that Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander each report beneficial interests in roughly 103,000 shares of common stock, representing about 9.6% of the class on the cover pages.

The filing states these holdings are held by entities subject to voting control and investment discretion by Millennium Management LLC and related managers, and includes a Joint Filing Agreement dated February 23, 2026.

Positive

  • None.

Negative

  • None.

Insights

Large passive position disclosed by Millennium-affiliated group; holdings near double-digit stake.

The filing lists 103,026 and 102,971 share figures and shows a reported 9.6% ownership percentage on the cover pages. It identifies Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander as joint filers.

The filing notes the shares are held by entities under the voting or investment discretion of Millennium Management LLC and/or related managers; the Joint Filing Agreement dated February 23, 2026 formalizes the group filing. Subsequent disclosures may clarify any changes to voting or disposition powers.

Group filing clarifies shared voting/dispositive power rather than sole control.

The cover-page details show Shared Voting Power and Shared Dispositive Power of 102,971103,026 shares for the named filers. The narrative explains these holdings are through entities subject to manager discretion.

Investors seeking clarity should watch for any amendments or Form 4 filings that convert shared authority into sole voting or dispositive actions; timing and further party-level detail are not in this excerpt.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Integrated Core Strategies (US) LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:02/23/2026
Millennium Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:02/23/2026
Millennium Group Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:02/23/2026
Israel A. Englander
Signature:/s/ Israel A. Englander
Name/Title:Israel A. Englander
Date:02/23/2026

Comments accompanying signature: ** INTEGRATED CORE STRATEGIES (US) LLC By: Integrated Holding Group LP, its Managing Member By: Millennium Management LLC, its General Partner
Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of February 23, 2026, by and among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.

FAQ

What stake does the Millennium group report in SPRB?

The filing shows each named filer reports roughly 103,000 shares, equal to about 9.6% of Spruce Biosciences' common stock per the cover pages. These figures appear on the Schedule 13G cover pages dated February 17, 2026 and signatures dated February 23, 2026.

Who are the joint filers listed on the Schedule 13G for SPRB?

The joint filing names Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander. A Joint Filing Agreement dated February 23, 2026 accompanies the schedule.

Do the filers claim sole voting or dispositive power over the shares?

No; the cover pages report zero sole voting and dispositive power and instead list shared voting and shared dispositive power at approximately 102,971–103,026 shares for the named filers, per the Item responses on the cover pages.

Does the Schedule 13G indicate these holdings are held directly by the filers?

The schedule explains the securities are held by entities subject to voting control and investment discretion by Millennium Management LLC and related managers; it cautions this should not be construed as an admission of beneficial ownership by those filers.

What document formalizes the group filing for SPRB?

The filing attaches an Exhibit I: Joint Filing Agreement dated February 23, 2026, executed by Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.
Spruce Biosciences, Inc.

OTC:SPRB

SPRB Rankings

SPRB Latest News

SPRB Latest SEC Filings

SPRB Stock Data

62.32M
971.52k
Pharmaceutical Preparations
Link
United States
SOUTH SAN FRANCISCO